DISTINCT T CELL ACTIVATION BY ANTIGEN PRESENTING CELLS
DISTINCT T CELL ACTIVATION BY ANTIGEN PRESENTING CELLS
批准号:
6100500
负责人:
SETH R STEVENS
金额:
$4.59万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-03-01 至 2001-02-28
关键词:
CD40 molecule Langerhans' cell antigen presenting cell cell adhesion molecules cell growth regulation cytokine enzyme linked immunosorbent assay flow cytometry immune tolerance /unresponsiveness leukocyte activation /transformation macrophage neutralizing antibody tissue /cell culture ultraviolet radiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Application of otherwise sensitizing haptens to ultraviolet irradiated
skin induces T cell-mediated immunologic tolerance. Along with other
changes in the cutaneous milieu, alterations in antigen presenting cell
(APC) populations in the epidermis occur after UV exposure. Six to 72
hours after UV exposure, infiltrating macrophages (UV-Mph) replace the
normal, indigenous dendritic APC, Langerhans cells, as the predominant
APC of epidermis. These UV-Mph have been shown to induce antigen
specific tolerance in mice and are associated with tolerance in humans.
The basic hypothesis driving my work is that these two APC, LC and UV-
Mph, which are associated with the distinct immune outcomes of
sensitization and tolerization, respectively, activate T cells in
distinct ways.
The proposed research will determine whether differences in
costimulatory molecules exist between LC and UV-Mph, and if so, whether
these are involved in distinct activational states of the T cells with
which they interact. Thus, flow cytometric analysis of the relative
expression of B7-1, B7-2, CD40, VCAM-1 and fibronectin by UV-Mph and
LC will be performed. The functional significance of differences will
be explored by determining the effect on T cell activation of
manipulations that alter the expression of these molecules or their
ability to send or receive signals. The T cell effects to be measured
are lL-2Ra (CD25) expression by flow cytometry, growth by tritiated
thymidine incorporation, and cytokine production (IL-2, IL-4, IL-5,
IFN-g) by ELISPOT. Manipulations of the system are to be addition of
recombinant cytokines to alter costimulatory molecule expression,
blocking antibodies to costimulatory molecules or their T cell ligands,
and addition of neutralizing antibodies to candidate growth factors
(lL-2, lL-4, lL-7 and IL-15).
The expected results are that previously published differences in T
cell CD25 expression are due to different utilization of costimulatory
molecules. These differences also lead to different T cell growth
factor use and cytokine production after activation by these two APC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T CELL ACTIVIATION BY DISTINCT ANTIGEN PRESENTING CELLS
-
批准号:6029910
-
项目类别:
-
资助金额:$10.84万
-
财政年份:1998
-
负责人:SETH R STEVENS
-
依托单位:
T CELL ACTIVIATION BY DISTINCT ANTIGEN PRESENTING CELLS
-
批准号:6511997
-
项目类别:
-
资助金额:$12.2万
-
财政年份:1998
-
负责人:SETH R STEVENS
-
依托单位:
T CELL ACTIVIATION BY DISTINCT ANTIGEN PRESENTING CELLS
-
批准号:2593293
-
项目类别:
-
资助金额:$8.81万
-
财政年份:1998
-
负责人:SETH R STEVENS
-
依托单位:
T CELL ACTIVIATION BY DISTINCT ANTIGEN PRESENTING CELLS
-
批准号:6171361
-
项目类别:
-
资助金额:$12.2万
-
财政年份:1998
-
负责人:SETH R STEVENS
-
依托单位:
T CELL ACTIVIATION BY DISTINCT ANTIGEN PRESENTING CELLS
-
批准号:6374750
-
项目类别:
-
资助金额:$12.2万
-
财政年份:1998
-
负责人:SETH R STEVENS
-
依托单位:
TREATMENT OF CTCL WITH O6 BENZYLGUANINE/BCNU
-
批准号:6044252
-
项目类别:
-
资助金额:$1.51万
-
财政年份:1997
-
负责人:SETH R STEVENS
-
依托单位:
TREATMENT OF CTCL WITH O6 BENZYLGUANINE/BCNU
-
批准号:2769952
-
项目类别:
-
资助金额:$12.87万
-
财政年份:1997
-
负责人:SETH R STEVENS
-
依托单位:
PILOT--T-CELL ACTIVATION BY UV-EXPOSED AND NORMAL SKIN CELLS
-
批准号:5206245
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:SETH R STEVENS
-
依托单位:--
海外基金